Company profile for Anew Medical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ANEW MEDICAL, INC. was founded to develop and provide disruptive new therapies to alleviate and/or reverse the progression of cancer and neurodegenerative diseases through the use of cell and gene therapy. Their goal is to develop innovative treatments for people with cancer, Alzheimer’s, Parkinson’s disease, and amyotrophic lateral sclerosis. Anew Medical is licensed exclusive rights to develop and commercialize two key p...
ANEW MEDICAL, INC. was founded to develop and provide disruptive new therapies to alleviate and/or reverse the progression of cancer and neurodegenerative diseases through the use of cell and gene therapy. Their goal is to develop innovative treatments for people with cancer, Alzheimer’s, Parkinson’s disease, and amyotrophic lateral sclerosis. Anew Medical is licensed exclusive rights to develop and commercialize two key product platform technologies – biosimilar biologics (antibodies made in host cells) against cancer, and human gene and protein therapy utilizing an important gene referred to as α-Klotho.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
13576 Walnut Street, Suite A Omaha, NE 68144
Telephone
Telephone
+1 (828) 888-8828
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/09/17/2947255/0/en/ANEW-MEDICAL-Inc-Announces-Name-Change-to-Klotho-Neurosciences-Inc.html

GLOBENEWSWIRE
17 Sep 2024

https://www.globenewswire.com/news-release/2024/09/04/2940419/0/en/Healthy-Longevity-is-One-of-Key-Development-Goals-of-ANEW-s-Novel-Gene-Therapy.html

GLOBENEWSWIRE
04 Sep 2024

https://www.globenewswire.com/news-release/2024/08/21/2933313/0/en/ANEW-MEDICAL-INC-Acquires-License-to-Needle-Free-Dry-Powder-Autoinjector-from-Transfertech-Sherbrooke-TTS.html

GLOBENEWSWIRE
21 Aug 2024
ANEW MEDICAL, INC. Appoints New CFO
ANEW MEDICAL, INC. Appoints New CFO

19 Aug 2024

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2024/08/19/2931951/0/en/ANEW-MEDICAL-INC-Appoints-New-CFO.html

GLOBENEWSWIRE
19 Aug 2024

https://www.globenewswire.com/news-release/2024/08/15/2930708/0/en/ANEW-MEDICAL-INC-Strengthens-Intellectual-Property-Protection-with-U-S-Patent-Issuance-for-Its-Secreted-RNA-Splice-Variant-of-the-Human-Klotho-Gene-Used-for-the-Treatment-of-Neurod.html

GLOBENEWSWIRE
15 Aug 2024

https://www.globenewswire.com/news-release/2024/08/09/2927628/0/en/ANEW-MEDICAL-INC-Pursues-Neurological-Approach-to-Treating-Weight-Loss-and-Eating-Disorders-through-Melanocortin-Receptor-Binding-Peptides.html

GLOBENEWSWIRE
09 Aug 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty